MCAP
vs
O
OMX Stockholm 30
MCAP
Over the past 12 months, MCAP has underperformed OMX Stockholm 30, delivering a return of +25% compared to the OMX Stockholm 30's +31% growth.
Stocks Performance
MCAP vs OMX Stockholm 30
Performance Gap
MCAP vs OMX Stockholm 30
Performance By Year
MCAP vs OMX Stockholm 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
MedCap AB (publ)
Glance View
MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.
